TY - JOUR
T1 - α-amino acid phenolic ester derivatives
T2 - Novel water-soluble general anesthetic agents which allosterically modulate gabaa receptors
AU - Anderson, Alison
AU - Belelli, Delia
AU - Bennett, Jonathan
AU - Buchanan, Kirsteen I.
AU - Casula, Anna
AU - Cooke, Andrew
AU - Feilden, Helen
AU - Gemmell, David K.
AU - Hamilton, Niall M.
AU - Hutchinson, Edward J.
AU - Lambert, Jeremy J.
AU - Maidment, Maurice S.
AU - McGuire, Ross
AU - McPhail, Petula
AU - Miller, Susan
AU - Muntoni, Annalisa
AU - Peters, John A.
AU - Sansbury, Francis H.
AU - Stevenson, Donald
AU - Sundaramt, Hardy
PY - 2001/10/25
Y1 - 2001/10/25
N2 - In the search for a novel water-soluble general anesthetic agent the activity of an α-amino acid phenolic ester lead, identified from patent literature, was markedly improved. In addition to improving in vivo activity in mice, good in vitro activity at GABAA receptors was also conferred. Within the series of compounds good enantioselectivity for both in vitro and in vivo activity was found, supporting a protein-mediated mechanism of action for anesthesia involving allosteric modulation of GABAA receptors. α-Amino acid phenolic ester 19, as the hydrobromide salt Org 25435, was selected for clinical evaluation since it retained the best overall anesthetic profile coupled with improved stability and water solubility. In the clinic it proved to be an effective intravenous anesthetic in man with rapid onset of and recovery from anesthesia at doses of 3 and 4 mg/kg.
AB - In the search for a novel water-soluble general anesthetic agent the activity of an α-amino acid phenolic ester lead, identified from patent literature, was markedly improved. In addition to improving in vivo activity in mice, good in vitro activity at GABAA receptors was also conferred. Within the series of compounds good enantioselectivity for both in vitro and in vivo activity was found, supporting a protein-mediated mechanism of action for anesthesia involving allosteric modulation of GABAA receptors. α-Amino acid phenolic ester 19, as the hydrobromide salt Org 25435, was selected for clinical evaluation since it retained the best overall anesthetic profile coupled with improved stability and water solubility. In the clinic it proved to be an effective intravenous anesthetic in man with rapid onset of and recovery from anesthesia at doses of 3 and 4 mg/kg.
U2 - 10.1021/jm010903i
DO - 10.1021/jm010903i
M3 - Article
C2 - 11606122
AN - SCOPUS:0035950078
SN - 0022-2623
VL - 44
SP - 3582
EP - 3591
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 22
ER -